Class 4 medicines defect information – Caution in Use – Diamorphine Hydrochloride BP Lyophilisate for Solution for Injection 100mg

18 Feb 2020

Ref: EL (20)A/09

17 February 2020

Diamorphine Hydrochloride BP Lyophilisate for Solution for Injection 100mg
(Manufactured by Accord Healthcare Ltd)

PL 20075/0675

A Class 4 medicines defect information alert has been issued by the Medicines & Healthcare products Regulatory Agency (MHRA) for specific batches of Diamorphine Hydrochloride BP Lyophilisate for Solution for Injection 100mg. Accord Healthcare Ltd has informed the MHRA of a discrepancy in specific batches which does not have the expiry date encoded in 2D data matrix leading to an error message displayed upon decommissioning.

Diamorphine Hydrochloride BP Lyophilisate for Solution for Injection 100mg

Batch number Expiry date Pack size
F19160 May 2022 1 x 5 ampoules
F19161 May 2022 1 x 5 ampoules

Further information can be found on the MHRA section on the GOV.UK website.

Produced by the NPA Pharmacy Services team February 2020.